Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine

Moderna, Inc. Investors: Company Investigated by the Portnoy Law Firm LOS ANGELES, May 27, 2020 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Moderna, Inc. ("Moderna") (NASDAQ: MRNA) investors that the firm has initiated an investigation into possible securities...